PATH VACCINE SOLUTIONS: Form 990, tax year 2014

View the entire original 990 at ProPublica ↗

Organization
PATH VACCINE SOLUTIONS (EIN 83-0431851)
Tax period
2014-01-01 to 2014-12-31
Filed
2015-11-09
IRS object ID
201523139349303152
Schema version
2014v5.0
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2015-11-09T16:44:35-06:00ReturnTs
Tax Period End2014-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN521392008PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1GELMAN ROSENBERG & FREEDMANBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line14550 MONTGOMERY AVE SUITE 650NAddressLine1Txt
CityBETHESDACityNm
State AbbreviationMDStateAbbreviationCd
ZIP208142930ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2014-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN830431851EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1PATH VACCINE SOLUTIONSBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlPATHBusinessNameControlTxt
Phone2062853500PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line12201 WESTLAKE AVENUE NO 200AddressLine1Txt
CitySEATTLECityNm
State AbbreviationWAStateAbbreviationCd
ZIP98121ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonOLIVIA POLIUSPersonNm
Person TitleCHIEF FINANCIAL OFFICERPersonTitleTxt
Phone2062853500PhoneNum
Signature2015-11-09SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Phone3019519090PhoneNum
FieldValueIRS element (for citing)
Tax2014TaxYr
Build TS2016-03-07 17:11:31ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerOLIVIA POLIUSPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line12201 WESTLAKE AVENUE NO 200AddressLine1Txt
CitySEATTLECityNm
State AbbreviationWAStateAbbreviationCd
ZIP98121ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$45,322,297GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.PATH.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2006FormationYr
Legal Domicile StateWALegalDomicileStateCd
Activity Or MissionSEE PART III, LINE 1.ActivityOrMissionDesc
Voting Members Governing Body7VotingMembersGoverningBodyCnt
Voting Members Independent2VotingMembersIndependentCnt
Total Employee0TotalEmployeeCnt
Total Volunteers0TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$58,520,241PYContributionsGrantsAmt
CY Contributions Grants$24,448,784CYContributionsGrantsAmt
PY Program Service Revenue$1,200PYProgramServiceRevenueAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$875,409PYInvestmentIncomeAmt
CY Investment Income$315,733CYInvestmentIncomeAmt
PY Other Revenue$2,365PYOtherRevenueAmt
CY Other Revenue$7,237CYOtherRevenueAmt
PY Total Revenue$59,399,215PYTotalRevenueAmt
CY Total Revenue$24,771,754CYTotalRevenueAmt
PY Grants And Similar Paid$28,816,531PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$36,562,862CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$0PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$0CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$0CYTotalFundraisingExpenseAmt
PY Other Expenses$8,673,859PYOtherExpensesAmt
CY Other Expenses$10,606,165CYOtherExpensesAmt
PY Total Expenses$37,490,390PYTotalExpensesAmt
CY Total Expenses$47,169,027CYTotalExpensesAmt
PY Revenues Less Expenses$21,908,825PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$22,397,273CYRevenuesLessExpensesAmt
Total Assets BOY$166,859,076TotalAssetsBOYAmt
Total Assets EOY$149,044,550TotalAssetsEOYAmt
Total Liabilities BOY$6,024,155TotalLiabilitiesBOYAmt
Total Liabilities EOY$10,278,308TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$160,834,921NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$138,766,242NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE MISSION OF PATH VACCINE SOLUTIONS (PVS) IS TO IMPROVE THE HEALTH OF CHILDREN IN LOW-INCOME COUNTRIES BY ACCELERATING THE DEVELOPMENT OF VACCINES THAT WILL BE EFFECTIVE AND AFFORDABLE FOR THOSE WHO NEED THEM MOST. FROM INITIAL DISCOVERY THROUGH CLINICAL TRIALS, PVS WORKS WITH COMMERCIAL PARTNERS, SUCH AS VACCINE MANUFACTURERS AND BIOTECHNOLOGY FIRMS, AND NONPROFIT PARTNERS, SUCH AS UNIVERSITIES AND RESEARCH INSTITUTIONS, TO SHORTEN THE TIMELINE FOR VACCINE DEVELOPMENT.PVS WORKS WITH PARTNERS TO DEVELOP NEW VACCINES BY PROVIDING FUNDING AND EXPERTISE IN PRECLINICAL DEVELOPMENT, MANUFACTURING, AND CLINICAL DEVELOPMENT, WITH A FOCUS ON LOW-RESOURCE COUNTRIES. IN RETURN, PARTNERS AGREE TO TERMS THAT HELP ENSURE THE RESULTING PRODUCTS ARE AFFORDABLE AND AVAILABLE IN DEVELOPING COUNTRIES.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$47,169,027ExpenseAmt
Grant$36,562,862GrantAmt
DescPVS WORKS TO PREVENT DEATH AND DISEASE CAUSED BY PNEUMONIA, INFLUENZA, RESPIRATORY SYNCYTIAL VIRUS, POLIO, AND DIARRHEA AMONG CHILDREN AROUND THE WORLD. WE ACCELERATE THE DEVELOPMENT OF SAFE, EFFICACIOUS, AND AFFORDABLE VACCINES IN PARTNERSHIP WITH PUBLIC AND PRIVATE GROUPS. IN 2014, PVS MARKED A SIGNIFICANT MILESTONE IN OUR WORK TO REDUCE CHILDHOOD DEATHS DUE TO DIARRHEAL DISEASE, WHICH IS THE SECOND-LEADING CAUSE OF DEATH AMONG CHILDREN IN THE DEVELOPING WORLD. OUR DECADE-LONG PARTNERSHIP WITH INDIAN VACCINE MANUFACTURER BHARAT BIOTECH TO DEVELOP A VACCINE AGAINST ROTAVIRUS, THE LEADING CAUSE OF SEVERE CHILDHOOD DIARRHEA, LED TO THE INDIAN GOVERNMENT'S 2014 LICENSURE OF THE VACCINE AND ANNOUNCEMENT OF ITS INCLUSION IN THE NATIONAL IMMUNIZATION PROGRAM. THROUGH THE YEARS, PVS PLAYED A SIGNIFICANT ROLE IN THIS EFFORT. THROUGH A UNIQUE PUBLIC-PRIVATE PARTNERSHIP, WE PROVIDED TECHNICAL ASSISTANCE THAT ACCELERATED CLINICAL DEVELOPMENT OF THIS IMPORTANT VACCINE.OUR EVALUATION OF VACCINES TO FIGHT PNEUMONIA, THE LEADING CAUSE OF CHILDHOOD DEATHS WORLDWIDE, ADVANCED WITH THE INITIATION OF PHASE 1/2 TRIALS IN AFRICA. IN THE GAMBIA, WE ARE EVALUATING A 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV-10), MANUFACTURED BY SERUM INSTITUTE OF INDIA, LTD. THE PCV-10 CANDIDATE IS DESIGNED TO BE AFFORDABLE AND FOCUSES ON VARIETIES OF THE PNEUMOCOCCUS BACTERIUM THAT ARE PREVALENT IN DEVELOPING COUNTRIES OF AFRICA. IN KENYA, WE ARE STUDYING A PNEUMOCOCCAL WHOLE CELL VACCINE THAT HAS POTENTIAL TO PROTECT CHILDREN AGAINST SEVERAL SEROTYPES OF PNEUMOCOCCAL DISEASE.ALSO IN 2014, PVS MARKED THE SUCCESSFUL COMPLETION OF IMPORTANT CLINICAL STUDIES TO EVALUATE AND OPTIMIZE INFLUENZA VACCINE. TRIALS IN BANGLADESH AND SENEGAL GENERATED EFFICACY AND ADDITIONAL SAFETY DATA ON THE SEASONAL LIVE, ATTENUATED INFLUENZA VACCINE AMONG CHILDREN AS YOUNG AS TWO YEARS OF AGE. THIS YIELDED IMPORTANT NEW INSIGHTS INTO THE PROTECTION OF YOUNG, VULNERABLE CHILDREN IN DEVELOPING COUNTRIES. ADDITIONALLY, A PHASE 1 STUDY OF THE LIVE, ATTENUATED A/H2N2 INFLUENZA VACCINE SUCCESSFULLY CONCLUDED IN 2014.Desc
Total Program Service Expenses$47,169,027TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Temp Or Permanent Endowments0TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other Liabilities0ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt0IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (1)ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign OfficeYes (1)ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To OrgYes (1)MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With Officer Ent0BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related EntityYes (1)RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document0IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Employee0EmployeeCnt
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members7GoverningBodyVotingMembersCnt
Independent Voting Member2IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEO0CompensationProcessCEOInd
Compensation Process Other0CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
Other WebsiteYes (X)OtherWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1OLIVIA POLIUS CHIEF FINANCIAL OFFICERBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone2062853500PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line12201 WESTLAKE AVE SUITE 200AddressLine1Txt
CitySEATTLECityNm
State AbbreviationWAStateAbbreviationCd
ZIP98121ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (8 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmt
STEVEN B DAVIS
CHAIR1.0039.00Yes (X)Yes (X)$0$569,984$43,512
PENNY HEATON
VICE CHAIR1.000.00Yes (X)Yes (X)$0$0$0
OLIVIA D POLIUS
TREASURER1.0039.00Yes (X)Yes (X)$0$255,770$39,644
AMIE E BATSON
DIRECTOR1.0039.00Yes (X)$0$275,229$32,472
DANIEL LASTER
DIRECTOR / GENERAL COUNSEL1.0039.00Yes (X)$0$250,848$39,180
DAVID C KASLOW
DIRECTOR1.0039.00Yes (X)$0$378,301$41,432
CHRIS KARP
DIRECTOR1.000.00Yes (X)$0$0$0
DAVID A ALLI
SECRETARY20.0020.00Yes (X)$0$156,435$28,858
FieldValueIRS element (for citing)
Total Reportable Comp From Org$0TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$1,886,567TotReportableCompRltdOrgAmt
Total Other Compensation$225,098TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K0IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp

Contractor Name ContractorName

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1NORTHERN TRUSTBusinessNameLine1Txt

Contractor Address ContractorAddress

US Address USAddress

FieldValueIRS element (for citing)
Address Line150 S LASALLE STAddressLine1Txt
CityCHICAGOCityNm
State AbbreviationILStateAbbreviationCd
ZIP60675ZIPCd
FieldValueIRS element (for citing)
ServicesASSET MANAGEMENTServicesDesc
Compensation$182,113CompensationAmt
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K1CntrctRcvdGreaterThan100KCnt
All Other Contributions$24,448,784AllOtherContributionsAmt
Total Contributions$24,448,784TotalContributionsAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$866,276TotalRevenueColumnAmt
Exclusion$866,276ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$20,000,000SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$20,550,543SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities-$550,543SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column-$550,543TotalRevenueColumnAmt
Exclusion-$550,543ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescOTHER REIMBURSEMENTSDesc
Business900099BusinessCd
Total Revenue Column$7,237TotalRevenueColumnAmt
Exclusion$7,237ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$7,237OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$24,771,754TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$322,970ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$26,167,231TotalAmt
Program Services$26,167,231ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$10,395,631TotalAmt
Program Services$10,395,631ProgramServicesAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$26,292TotalAmt
Program Services$26,292ProgramServicesAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$182,114TotalAmt
Program Services$182,114ProgramServicesAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$518,991TotalAmt
Program Services$518,991ProgramServicesAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$3,532TotalAmt
Program Services$3,532ProgramServicesAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$245,180TotalAmt
Program Services$245,180ProgramServicesAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$12,575TotalAmt
Program Services$12,575ProgramServicesAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$5,000TotalAmt
Program Services$5,000ProgramServicesAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$1,866,812TotalAmt
Program Services$1,866,812ProgramServicesAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$80,056TotalAmt
Program Services$80,056ProgramServicesAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$179,375TotalAmt
Program Services$179,375ProgramServicesAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmt
SUBCONTRACTORS$7,163,022$7,163,022
LAB SUPPLIES$217,659$217,659
EQUIPMENT R&M$55,773$55,773
STORAGE$32,676$32,676

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$17,108TotalAmt
Program Services$17,108ProgramServicesAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$47,169,027TotalAmt
Program Services$47,169,027ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$5,006,227BOYAmt
EOY$15,650,996EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$69,342,564BOYAmt
EOY$60,119,568EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$217,893BOYAmt
EOY$126,845EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$32,953BOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$227,541LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$63,833LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$6,934BOYAmt
EOY$163,708EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$92,252,505BOYAmt
EOY$72,983,433EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$166,859,076BOYAmt
EOY$149,044,550EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$6,024,155BOYAmt
EOY$10,278,308EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$6,024,155BOYAmt
EOY$10,278,308EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$150BOYAmt
EOY$37,582EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$160,834,771BOYAmt
EOY$138,728,660EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$160,834,921BOYAmt
EOY$138,766,242EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$166,859,076BOYAmt
EOY$149,044,550EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss-$22,397,273ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$328,594NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Supporting Organization509a3Yes (X)SupportingOrganization509a3Ind
Supporting Org Type1Yes (X)SupportingOrgType1Ind
Supported Organizations1SupportedOrganizationsCnt

Supported Org Information SupportedOrgInformationGrp

Supported Organization Name SupportedOrganizationName

FieldValueIRS element (for citing)
Business Name Line1PATHBusinessNameLine1Txt
FieldValueIRS element (for citing)
EIN911157127EIN
Organization TypeBOX 7OrganizationTypeDesc
Governing Document ListedYes (1)GoverningDocumentListedInd
Support$47,169,027SupportAmt
Other Support$0OtherSupportAmt
FieldValueIRS element (for citing)
Supported Organizations Total1SupportedOrganizationsTotalCnt
Support Sum$47,169,027SupportSumAmt

Form990 Sch A Supporting Org Form990SchASupportingOrgGrp

FieldValueIRS element (for citing)
Listed By Name Governing DocYes (1)ListedByNameGoverningDocInd
Suprt Org No IRS Determination0SuprtOrgNoIRSDeterminationInd
Supported Org Section C4560SupportedOrgSectionC456Ind
Supported Org Not Organized US0SupportedOrgNotOrganizedUSInd
Organization Change Suprt Org0OrganizationChangeSuprtOrgInd
Support Non Supported OrgYes (1)SupportNonSupportedOrgInd
Payment Substantial Contribtr0PaymentSubstantialContribtrInd
Loan Disqualified Person0LoanDisqualifiedPersonInd
Controlled Disqualified Prsn0ControlledDisqualifiedPrsnInd
Disqualified Prsn Controll Int0DisqualifiedPrsnControllIntInd
Disqualified Prsn Ownr Int0DisqualifiedPrsnOwnrIntInd
Excess Business Holdings Rules0ExcessBusinessHoldingsRulesInd
Contribution Controller0ContributionControllerInd
Contribution Family0ContributionFamilyInd
Contribution35 Controlled0Contribution35ControlledInd

Form990 Sch A Type1 Suprt Org Form990SchAType1SuprtOrgGrp

FieldValueIRS element (for citing)
Power Appoint Majority Dir TrstYes (1)PowerAppointMajorityDirTrstInd
Operate Benefit Non Suprt Org0OperateBenefitNonSuprtOrgInd

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp

FieldValueIRS element (for citing)
Form And Line ReferencePART IV, SECTION A, LINE 6:FormAndLineReferenceDesc
ExplanationPATH VACCINE SOLUTIONS PROVIDED VARIOUS GRANTS DETAILED IN SCHEDULES F AND I.ExplanationTxt

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$227,541OtherCostOrOtherBasisAmt
Depreciation$63,833DepreciationAmt
Book Value$163,708BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$163,708TotalBookValueLandBuildingsAmt

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (12 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
EAST ASIA AND THE PACIFIC00PROGRAM SERVICESPRODUCT DEVELOPMENT$261,540
EAST ASIA AND THE PACIFIC00GRANTMAKING$1,172,534
EUROPE00PROGRAM SERVICESPRODUCT DEVELOPMENT$635,222
EUROPE00GRANTMAKING$2,811,050
NORTH AMERICA00PROGRAM SERVICESPRODUCT DEVELOPMENT$38,848
RUSSIA AND NEIGHBORING STATES00PROGRAM SERVICESPRODUCT DEVELOPMENT$385,829
RUSSIA AND NEIGHBORING STATES00GRANTMAKING$210,356
SOUTH AMERICA00PROGRAM SERVICESPRODUCT DEVELOPMENT$5,479
SOUTH ASIA010PROGRAM SERVICESPRODUCT DEVELOPMENT$844,547
SOUTH ASIA00GRANTMAKING$5,590,814
SUB-SAHARAN AFRICA00PROGRAM SERVICESPRODUCT DEVELOPMENT$947,134
SUB-SAHARAN AFRICA00GRANTMAKING$610,877
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees0SubtotalEmployeesCnt
Continutation Total Office0ContinutationTotalOfficeCnt
Continutation Total Employee10ContinutationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee10TotalEmployeeCnt
Subtotal Spent$5,520,858SubtotalSpentAmt
Continuation Spent$7,993,372ContinuationSpentAmt
Total Spent$13,514,230TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (23 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxt
EAST ASIA AND THE PACIFICPRODUCT DEVELOPMENT$1,172,534CHECK/WIRE
EUROPEPRODUCT DEVELOPMENT$52,095CHECK/WIRE
EUROPEPRODUCT DEVELOPMENT$109,786CHECK/WIRE
EUROPEPRODUCT DEVELOPMENT$230,160CHECK/WIRE
EUROPEPRODUCT DEVELOPMENT$378,357CHECK/WIRE
EUROPEPRODUCT DEVELOPMENT$1,925,000CHECK/WIRE
EUROPEPRODUCT DEVELOPMENT$15,865CHECK/WIRE
EUROPEPRODUCT DEVELOPMENT$153,189CHECK/WIRE
RUSSIA AND NEIGHBORING STATESPRODUCT DEVELOPMENT$210,356CHECK/WIRE
SOUTH ASIAPRODUCT DEVELOPMENT$7,768CHECK/WIRE
SOUTH ASIAPRODUCT DEVELOPMENT$2,175,385CHECK/WIRE
SOUTH ASIAPRODUCT DEVELOPMENT$457,534CHECK/WIRE
SOUTH ASIAPRODUCT DEVELOPMENT$189,490CHECK/WIRE
SOUTH ASIAPRODUCT DEVELOPMENT$470,647CHECK/WIRE
SOUTH ASIAPRODUCT DEVELOPMENT$942,745CHECK/WIRE
SOUTH ASIAPRODUCT DEVELOPMENT$511,471CHECK/WIRE
SOUTH ASIAPRODUCT DEVELOPMENT$258,112CHECK/WIRE
SOUTH ASIAPRODUCT DEVELOPMENT$577,662CHECK/WIRE
SUB-SAHARAN AFRICAPRODUCT DEVELOPMENT$15,000CHECK/WIRE
SUB-SAHARAN AFRICAPRODUCT DEVELOPMENT$6,584CHECK/WIRE
SUB-SAHARAN AFRICAPRODUCT DEVELOPMENT$100,000CHECK/WIRE
SUB-SAHARAN AFRICAPRODUCT DEVELOPMENT$489,293CHECK/WIRE
EUROPEPRODUCT DEVELOPMENT-$56,438CHECK/WIRE
FieldValueIRS element (for citing)
Total501c3 Org17Total501c3OrgCnt
Total Other Org5TotalOtherOrgCnt
Transfer To Foreign CorpYes (1)TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationSUBRECIPIENTS ARE REQUIRED TO SUBMIT PROGRESS REPORTS, WHICH ARE REVIEWED BY RESPONSIBLE PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS TO ENSURE THAT PROGRAM GOALS ARE ATTAINED IN ACCORDANCE WITH AGREEMENT REQUIREMENTS. THE RESPONSIBLE PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS CONTACT SUBRECIPIENTS WITH QUESTIONS AND FOLLOW UP ON ANY CONCERNS. IN SOME CASES, SUBAWARD TERMS MAY REQUIRE SPECIFIED DELIVERABLES IN ADDITION TO, OR IN LIEU OF, TECHNICAL AND FINANCIAL REPORTS. DISCRETIONARY ON-SITE VISITS ARE ALSO CONDUCTED TO EVALUATE BOTH COMPLIANCE WITH THE SCIENTIFIC OBJECTIVES OF THE PROJECT AND APPROPRIATENESS OF THE SUBRECIPIENT'S ADMINISTRATIVE SYSTEMS AND PROCESSES.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (23 entries)

Address Line1USAddress/AddressLine1TxtAddress Line2USAddress/AddressLine2TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxt
ADVANCED BIOSCIENCE LABRATORIES INC
9800 MEDICAL CENTER DRIVE BUILDINGDROCKVILLEMD20850621242262N/A$8,680PRODUCT DEVELOPMENT
BIOPROCESS TECHNOLOGY CONSULTANTS INC
12 GILL STREET SUITE 5450WOBURNMA01801100002382N/A$9,000PRODUCT DEVELOPMENT
BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA
701 20TH STREET SOUTH AB 1170BIRMINGHAMAL352940111636005396501(C)(3)$274,401PRODUCT DEVELOPMENT
BOSTON CHILDREN'S HOSPITAL
300 LONGWOOD AVENUEBOSTONMA02115042774441501(C)(3)$440,082PRODUCT DEVELOPMENT
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
3333 BURNET AVENUECINCINNATIOH45229310833936501(C)(3)$24,762PRODUCT DEVELOPMENT
FHI 360
FHI 360 HEADQUARTERS 359 BLACKWELLST SUITE 201DURHAMNC27701941646278501(C)(3)$1,307,219PRODUCT DEVELOPMENT
FINA BIOSOLUTIONS LLC
9430 KEY WEST AVE SUITE 200ROCKVILLEMD20850205448275N/A$131,671PRODUCT DEVELOPMENT
HARVARD UNIVERSITY SCHOOL OF PUBLIC HEALTH
INTERNATIONAL HEALTH 677 HUNTINGTONAVENUEBOSTONMA02115042103580501(C)(3)$178,855PRODUCT DEVELOPMENT
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
1428 MADISON AVENUENEW YORKNY10029136171197501(C)(3)$236,089PRODUCT DEVELOPMENT
JHU BLOOMBERG SCHOOL OF PUBLIC HEALTH
615 N WOLFE STREETBALTIMOREMD21205131687001501(C)(3)$21,561PRODUCT DEVELOPMENT
JOHNS HOPKINS UNIVERSITY
615 N WOLFE STREET W1100BALTIMOREMD21205131687001501(C)(3)$1,129,609PRODUCT DEVELOPMENT
LIQUIDIA TECHNOLOGIES INC
419 DAVIS DRIVE SUITE 100DURHAMNC27713201926605N/A$170,028PRODUCT DEVELOPMENT
NOVAVAX INC
20 FIRSTFIELD ROADROCKVILLEMD20878222716046N/A$2,804,370PRODUCT DEVELOPMENT
OKLAHOMA STATE UNIVERSITY
203 WHITEHURST HALLSTILLWATEROK74078736017987501(C)(3)$39,028PRODUCT DEVELOPMENT
SEATTLE CHILDREN'S HOSPITAL
4800 SAND POINT WAY NESEATTLEWA98105911156519501(C)(3)$138,896PRODUCT DEVELOPMENT
TULANE EDUCATIONAL FUND
1430 TULANE AVENUE TB-32NEW ORLEANSLA701122632720423889501(C)(3)$90,900PRODUCT DEVELOPMENT
UNITED STATES NAVAL MEDICAL RESEARCH CENTER
503 ROBERT GRANT AVESILVER SPRINGMD209107500470100048GOVERNMENT$471,558PRODUCT DEVELOPMENT
UNIVERSITY OF ALABAMA AT BIRMINGHAM
701 20TH STREET SOUTH AB 1170BIRMINGHAMAL35294636005396501(C)(3)$121,437PRODUCT DEVELOPMENT
UNIVERSITY OF FLORIDA
219 GRINTER HALL PO BOX 115500GAINESVILLEFL326115500596002052501(C)(3)$15,176PRODUCT DEVELOPMENT
UNIVERSITY OF MARYLAND BALTIMORE
PO BOX 41428BALTIMOREMD212036428526002033501(C)(3)$455,971PRODUCT DEVELOPMENT
WALTER REED ARMY INSTITUTE OF RESEARCH
503 ROBERT GRANT DRIVESILVER SPRINGMD20910520664528GOVERNMENT$2,375,896PRODUCT DEVELOPMENT
WASHINGTON UNIVERSITY
ONE BROOKINGS DRIVE CAMPUS BOX 10541054ST LOUISMO63130430653611501(C)(3)$134,870PRODUCT DEVELOPMENT
PATH
2201 WESTLAKE AVE SUITE 200SEATTLEWA98121911157127501(C)(3)$15,586,258PRODUCT DEVELOPMENT
FieldValueIRS element (for citing)
Total501c3 Org18Total501c3OrgCnt
Total Other Org5TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationSUBRECIPIENTS ARE REQUIRED TO SUBMIT PROGRESS REPORTS, WHICH ARE REVIEWED BY RESPONSIBLE PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS TO ENSURE THAT PROGRAM GOALS ARE ATTAINED IN ACCORDANCE WITH AGREEMENT REQUIREMENTS. THE RESPONSIBLE PROGRAM MANAGERS AND PROGRAM ADMINISTRATORS CONTACT SUBRECIPIENTS WITH QUESTIONS AND FOLLOW UP ON ANY CONCERNS. IN SOME CASES, SUBAWARD TERMS MAY REQUIRE SPECIFIED DELIVERABLES IN ADDITION TO, OR IN LIEU OF, TECHNICAL AND FINANCIAL REPORTS. IN ADDITION, DISCRETIONARY ON-SITE VISITS ARE CONDUCTED TO EVALUATE BOTH COMPLIANCE WITH THE SCIENTIFIC OBJECTIVES OF THE PROJECT AND THE APPROPRIATENESS OF THE SUBRECIPIENT'S ADMINISTRATIVE SYSTEMS AND PROCESSES.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (6 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
STEVEN B DAVIS
CHAIR$0$421,692$0$147,592$0$700$0$31,000$0$12,512$0$613,496$0$0
OLIVIA D POLIUS
TREASURER$0$255,000$0$0$0$770$0$30,281$0$9,363$0$295,414$0$0
AMIE E BATSON
DIRECTOR$0$275,004$0$0$0$225$0$31,000$0$1,472$0$307,701$0$0
DANIEL LASTER
DIRECTOR / GENERAL COUNSEL$0$250,008$0$0$0$840$0$26,668$0$12,512$0$290,028$0$0
DAVID C KASLOW
DIRECTOR$0$377,000$0$0$0$1,301$0$28,920$0$12,512$0$419,733$0$0
DAVID A ALLI
SECRETARY$0$156,435$0$0$0$0$0$17,483$0$11,375$0$185,293$0$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 3FormAndLineReferenceDesc
ExplanationPATH VACCINE SOLUTIONS RELIES ON A RELATED ORGANIZATION, PATH, TO DETERMINE COMPENSATION. PATH USES THE FOLLOWING TO ESTABLISH COMPENSATION OF THE EXECUTIVE DIRECTOR: - INDEPENDENT COMPENSATION CONSULTANT - COMPENSATION COMMITTEE - COMPENSATION SURVEY OR STUDY - APPROVAL BY THE BOARD OR COMPENSATION COMMITTEEExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART VI, SECTION B, LINE 11THE FORM 990 WAS PREPARED BY THE OUTSIDE ACCOUNTING FIRM USING INFORMATION PROVIDED BY PATH ACCOUNTING SERVICES STAFF. PATH SENIOR MANAGEMENT REVIEWED THE DRAFT FORM. A COPY OF THE 990 WAS SENT TO THE BOARD OF DIRECTORS FOR COMMENT. AFTER THE COMMENT PERIOD, THE CFO SIGNED THE RETURN.
FORM 990, PART VI, SECTION B, LINE 12CPVS HAS A WRITTEN CONFLICT OF INTEREST POLICY UNDER WHICH ALL PVS BOARD MEMBERS AND OFFICERS MUST COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM EACH YEAR. PVS DOES NOT HAVE EMPLOYEES. PVS IS A SUPPORTING ORGANIZATION TO PATH WITHIN THE MEANING OF IRC SECTION 509(A)(3), AND PVS CONTRACTS WITH PATH FOR MANAGEMENT SERVICES. PATH HAS A WRITTEN CONFLICT OF INTEREST POLICY UNDER WHICH ALL PATH BOARD MEMBERS, OFFICERS, AND STAFF ABOVE A DESIGNATED LEVEL MUST COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM EACH YEAR. ALL PVS AND PATH DISCLOSURE FORMS ARE REVIEWED AND KEPT ON FILE. A CONFLICT MANAGEMENT PLAN IS DEVELOPED FOR ANY EMPLOYEE WITH A SIGNIFICANT ACTUAL OR PERCEIVED CONFLICT OF INTEREST.
FORM 990, PART VI, SECTION C, LINE 19PVS'S FINANCIAL STATEMENTS, GOVERNING DOCUMENTS, AND CONFLICT OF INTEREST POLICY ARE MADE AVAILABLE TO THE PUBLIC UPON REQUEST; MOST DOCUMENTS ARE ALSO AVAILABLE ONLINE.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (3 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile StateLegalDomicileStateCdExempt Code SectionExemptCodeSectionTxtPublic Charity StatusPublicCharityStatusTxtDirect Controlling NADirectControllingNACdControlled OrganizationControlledOrganizationIndBusiness Name Line1DirectControllingEntityName/BusinessNameLine1TxtAddress Line1ForeignAddress/AddressLine1TxtCityForeignAddress/CityNmCountryForeignAddress/CountryCdLegal Domicile Foreign CountryLegalDomicileForeignCountryCd
PATH
2201 WESTLAKE AVE SUITE 200SEATTLEWA98121911157127GLOBAL HEALTHWA501(C)(3)LINE 7N/A0
PATH DRUG SOLUTIONS
280 UTAH AVENUE SUITE 250SAN FRANCISCOCA94080943384500DEVELOPMENT & DISTRIBUTION OF SAFE, EFFECTIVE, AND AFFORDABLE MEDICINESCA501(C)(3)LINE 11AYes (1)PATH
FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND
EDUCATIONAL AND SCIENTIFIC PROMOTION OF HEALTHN/AN/AYes (1)PATH207 ROUTE DE FERNEY 1218 LE GRAND-SGENEVASZSZ
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts Rylts0ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth OrgYes (1)GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org0GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org0LoansOrGuaranteesFromOthOrgInd
Div Related Organization0DivRelatedOrganizationInd
Asset Sale To Other Org0AssetSaleToOtherOrgInd
Asset Purchase From Other Org0AssetPurchaseFromOtherOrgInd
Asset Exchange0AssetExchangeInd
Rental Of Facilities To Oth Org0RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org0RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org0PerformOfServicesForOthOrgInd
Perform Of Services By Other Org0PerformOfServicesByOtherOrgInd
Sharing Of Facilities0SharingOfFacilitiesInd
Paid Employees Sharing0PaidEmployeesSharingInd
Reimbursement Paid To Other Org0ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org0ReimbursementPaidByOtherOrgInd
Transfer To Other Org0TransferToOtherOrgInd
Transfer From Other Org0TransferFromOtherOrgInd

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.